Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
14,277.00
12,207.00
10,260.00
8,749.00
7,781.00
6,214.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
14,277.00
12,207.00
10,260.00
8,749.00
7,781.00
6,214.00
Expenditure (Ex Depriciation)
Stock Adjustments
36.00
-183.00
-94.00
289.00
-449.00
-247.00
Raw Materials Consumed
4,016.00
3,672.00
3,252.00
2,622.00
2,871.00
2,028.00
Power & Fuel Cost
183.00
149.00
125.00
108.00
103.00
82.00
Employee Cost
3,183.00
2,692.00
2,260.00
1,918.00
1,620.00
1,415.00
Operating Expenses
309.00
254.00
206.00
139.00
114.00
93.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1,325.00
1,164.00
924.00
638.00
708.00
587.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
149.00
161.00
124.00
151.00
121.00
106.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
10,655.00
9,186.00
7,745.00
6,847.00
5,791.00
4,565.00
Operating Profit (PBDIT) excl Other Income
3,622.00
3,020.00
2,515.00
1,901.00
1,990.00
1,649.00
Other Income
358.00
536.00
280.00
128.00
196.00
170.00
Operating Profit (PBDIT)
3,981.00
3,557.00
2,795.00
2,030.00
2,186.00
1,820.00
Interest
644.00
431.00
34.00
45.00
59.00
21.00
Profit before Depriciation and Tax
3,336.00
3,125.00
2,761.00
1,984.00
2,126.00
1,798.00
Depreciation
886.00
621.00
378.00
325.00
166.00
118.00
Profit Before Taxation & Exceptional Items
2,450.00
2,504.00
2,382.00
1,658.00
1,960.00
1,679.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
2,332.00
2,516.00
2,397.00
1,671.00
1,974.00
1,691.00
Provision for Tax
394.00
509.00
457.00
361.00
521.00
398.00
Profit After Tax
1,926.00
1,994.00
1,925.00
1,297.00
1,438.00
1,281.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
11,907.00
9,918.00
8,012.00
6,735.00
5,303.00
4,065.00
Profit Available for appropriations
13,820.00
11,905.00
9,924.00
8,017.00
6,736.00
5,330.00
Appropriations
13,820.00
11,905.00
9,924.00
8,017.00
6,736.00
5,330.00
Equity Dividend (%)
100.00%
0.00%
0.00%
0.00%
0.00%
755.00%
Earnings Per Share
46.35
49.28
47.75
32.00
35.78
31.59
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 16.96% vs 18.98% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 19.93% vs 20.09% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 49.15% vs 1,161.54% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -3.41% vs 3.57% in Mar 2025
Compare Profit and Loss Results of Mankind Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
14,277.00
28,162.00
-13,885.00
-49.30%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
14,277.00
28,162.00
-13,885.00
-49.30%
Expenditure (Ex Depriciation)
Stock Adjustments
36.00
-743.00
779.00
104.85%
Raw Materials Consumed
4,016.00
10,292.00
-6,276.00
-60.98%
Power & Fuel Cost
183.00
416.00
-233.00
-56.01%
Employee Cost
3,183.00
5,366.00
-2,183.00
-40.68%
Operating Expenses
309.00
1,652.00
-1,343.00
-81.30%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1,325.00
1,934.00
-609.00
-31.49%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
149.00
963.00
-814.00
-84.53%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
10,655.00
22,279.00
-11,624.00
-52.17%
Operating Profit (PBDIT) excl Other Income
3,622.00
5,882.00
-2,260.00
-38.42%
Other Income
358.00
882.00
-524.00
-59.41%
Operating Profit (PBDIT)
3,981.00
6,764.00
-2,783.00
-41.14%
Interest
644.00
54.00
590.00
1,092.59%
Profit before Depriciation and Tax
3,336.00
6,710.00
-3,374.00
-50.28%
Depreciation
886.00
1,210.00
-324.00
-26.78%
Profit Before Taxation & Exceptional Items
2,450.00
5,499.00
-3,049.00
-55.45%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2,332.00
5,223.00
-2,891.00
-55.35%
Provision for Tax
394.00
1,353.00
-959.00
-70.88%
Profit After Tax
1,926.00
3,869.00
-1,943.00
-50.22%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
11,907.00
25,644.00
-13,737.00
-53.57%
Profit Available for appropriations
13,820.00
29,523.00
-15,703.00
-53.19%
Appropriations
13,820.00
29,523.00
-15,703.00
-53.19%
Equity Dividend (%)
100%
650%
-550.00
Earnings Per Share
46.35
48.03
-1.68
-3.50%
Profit And Loss - Net Sales
Net Sales 14,277.64 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 16.96% vs 18.98% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,622.38 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.93% vs 20.09% in Mar 2025
Profit And Loss - Interest
Interest 644.25 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 49.15% vs 1,161.54% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 1,926.41 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -3.41% vs 3.57% in Mar 2025